[HTML][HTML] JAK inhibitors and autoimmune rheumatic diseases

M Benucci, P Bernardini, C Coccia, R De Luca… - Autoimmunity …, 2023 - Elsevier
The four Janus kinase (JAK) proteins and the seven Signal Transducers of Activated
Transcription (STAT) mediate intracellular signal transduction downstream of cytokine …

Perspectives of JAK inhibitors for large vessel vasculitis

R Watanabe, M Hashimoto - Frontiers in Immunology, 2022 - frontiersin.org
Vasculitis is an inflammation of the blood vessels caused by autoimmunity and/or
autoinflammation, and recent advances in research have led to a better understanding of its …

Novel therapies in Takayasu arteritis

F Regola, M Uzzo, P Toniati, B Trezzi, RA Sinico… - Frontiers in …, 2022 - frontiersin.org
Takayasu Arteritis (TAK) is a large-vessel vasculitis that preferentially involves the aorta and
its primary branches. Cardiac involvement is frequent in TAK and is a major determinant of …

Interferon signature in giant cell arteritis aortitis

M Vieira, P Régnier, A Maciejewski-Duval… - Journal of …, 2022 - Elsevier
Objectives Molecular mechanisms underlying large-vessel involvement in giant cell arteritis
(LV-GCA) are largely unknown. Herein, we explore the critical involvement of pro …

JAK inhibitors and black box warnings: what is the future for JAK inhibitors?

K Tokareva, P Reid, V Yang, D Liew… - Expert Review of …, 2023 - Taylor & Francis
ABSTRACT Introduction Janus kinase inhibitors (JAKi) have dramatically improved the
treatment of various autoimmune and myeloproliferative disorders. Recently, concern has …

Treatment Options in Pediatric Behçet's Disease

T Giani, AF Luppino, G Ferrara - Pediatric Drugs, 2023 - Springer
Behçet's disease is a rare and poorly understood vasculitis affecting blood vessels of all
types and sizes. Uveitis and oral and genital ulcers represent the typical clinical triad …

Anti-inflammatory treatment of Kawasaki disease: comparison of current guidelines and perspectives

P Buda, J Friedman-Gruszczyńska, J Książyk - Frontiers in Medicine, 2021 - frontiersin.org
Kawasaki disease (KD), an acute, generalized vasculitis, is associated with an increased
risk of coronary heart disease and is the most common cause of acquired heart disease in …

Current developments in the diagnosis and treatment of giant cell arteritis

D Szekeres, B Al Othman - Frontiers in Medicine, 2022 - frontiersin.org
Giant cell arteritis is the most common vasculitis in adults above 50 years old. The disease is
characterized by granulomatous inflammation of medium and large arteries, particularly the …

[HTML][HTML] The roles of immune cells in Behçet's disease

D Hu, JL Guan - Advances in Rheumatology, 2023 - SciELO Brasil
Behçet's disease (BD) is a systemic vasculitis that can affect multiple systems, including the
skin, mucous membranes, joints, eyes, gastrointestinal and nervous. However, the …

Baricitinib for the treatment of refractory vascular Behçet's disease

Z Wang, X Wang, W Liu, Y Wang, J Liu, L Zhang… - Clinical …, 2023 - Elsevier
Objective The pilot study aims to evaluate the effectiveness and safety of baricitinib in
Behcet's Disease (BD) patients with refractory vascular involvement. Methods We …